Healthcare provider profile · identity verified

Todd Hunter Robinson, MD

Family Practice · CEDARTOWN, GA · NPI 1093870354

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	380	107
Omeprazole	Omeprazole	346	114
Atorvastatin Calcium	Atorvastatin Calcium	344	95
Amlodipine Besylate	Amlodipine Besylate	297	90
Rosuvastatin Calcium	Rosuvastatin Calcium	234	82
Metformin Hcl	Metformin Hcl	233	70
Lisinopril	Lisinopril	208	60
Pioglitazone Hcl	Pioglitazone Hcl	204	62
Zolpidem Tartrate	Zolpidem Tartrate	204	41
Pravastatin Sodium	Pravastatin Sodium	181	52
Valsartan	Valsartan	166	49
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	143	48
Gabapentin	Gabapentin	142	45
Memantine Hcl	Memantine Hcl	141	37
Famotidine	Famotidine	132	44
Alprazolam	Alprazolam	125	20
Tramadol Hcl	Tramadol Hcl	125	21
Metoprolol Tartrate	Metoprolol Tartrate	123	38
Pantoprazole Sodium	Pantoprazole Sodium	123	40
Tamsulosin Hcl	Tamsulosin Hcl	114	38
Metoprolol Succinate	Metoprolol Succinate	113	37
Simvastatin	Simvastatin	113	33
Citalopram Hbr	Citalopram Hydrobromide	111	26
Meloxicam	Meloxicam	107	34
Allopurinol	Allopurinol	106	30
Ezetimibe	Ezetimibe	97	33
Irbesartan	Irbesartan	93	23
Jardiance	Empagliflozin	89	16
Nifedipine Er	Nifedipine	89	27
Trazodone Hcl	Trazodone Hcl	85	31
Metformin Hcl Er	Metformin Hcl	84	27
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	83	27
Bupropion Xl	Bupropion Hcl	82	21
Donepezil Hcl	Donepezil Hcl	82	24
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	82	22
Mounjaro	Tirzepatide	79	19
Duloxetine Hcl	Duloxetine Hcl	77	25
Sertraline Hcl	Sertraline Hcl	70	17
Escitalopram Oxalate	Escitalopram Oxalate	68	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	21
Mirtazapine	Mirtazapine	66	24
Ropinirole Hcl	Ropinirole Hcl	66	17
Clonazepam	Clonazepam	62	suppressed
Potassium Chloride	Potassium Chloride	62	21
Buspirone Hcl	Buspirone Hcl	54	20
Furosemide	Furosemide	54	18
Labetalol Hcl	Labetalol Hcl	54	18
Triamcinolone Acetonide	Triamcinolone Acetonide	52	32
Celecoxib	Celecoxib	51	20
Hydrochlorothiazide	Hydrochlorothiazide	51	17
Losartan Potassium	Losartan Potassium	50	16
Pregabalin	Pregabalin	49	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	47	17
Methocarbamol	Methocarbamol	47	18
Esomeprazole Magnesium	Esomeprazole Magnesium	46	13
Myrbetriq	Mirabegron	45	suppressed
Carvedilol	Carvedilol	44	13
Benazepril Hcl	Benazepril Hcl	42	13
Lansoprazole	Lansoprazole	42	11
Ozempic	Semaglutide	42	13
Anastrozole	Anastrozole	41	16
Fluoxetine Hcl	Fluoxetine Hcl	40	11
Synthroid	Levothyroxine Sodium	40	12
Estradiol	Estradiol	38	11
Clopidogrel	Clopidogrel Bisulfate	37	14
Eliquis	Apixaban	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	14
Raloxifene Hcl	Raloxifene Hcl	37	11
Torsemide	Torsemide	37	17
Azithromycin	Azithromycin	36	35
Atenolol	Atenolol	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Eszopiclone	Eszopiclone	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	27
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Cefuroxime	Cefuroxime Axetil	28	23
Ondansetron Odt	Ondansetron	28	17
Spironolactone	Spironolactone	28	suppressed
Lorazepam	Lorazepam	27	suppressed
Prolia	Denosumab	27	16
Propranolol Hcl	Propranolol Hcl	27	suppressed
Topiramate	Topiramate	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	24
Tradjenta	Linagliptin	25	suppressed
Trulicity	Dulaglutide	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Diazepam	Diazepam	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Mupirocin	Mupirocin	18	11
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fosinopril Sodium	Fosinopril Sodium	16	suppressed
Np Thyroid	Thyroid,pork	16	suppressed
Xarelto	Rivaroxaban	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Prednisone	Prednisone	14	13
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Fluconazole	Fluconazole	13	12
Ibu	Ibuprofen	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Metronidazole	Metronidazole	13	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levofloxacin	Levofloxacin	12	12
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Naproxen	Naproxen	11	suppressed
Progesterone	Progesterone, Micronized	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error